Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling

(2018) Jeanne S. Mandelblatt et al.   MEDICAL DECISION MAKING

Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches

(2018) Nicolien T. van Ravesteyn et al.   MEDICAL DECISION MAKING

Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening

(2016) Diana L. Miglioretti et al.   ANNALS OF INTERNAL MEDICINE

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

(2016) Jeanne S. Mandelblatt et al.   ANNALS OF INTERNAL MEDICINE

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes

(2016) Amy Trentham-Dietz et al.   ANNALS OF INTERNAL MEDICINE

Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts

(2015) Brian L. Sprague et al.   ANNALS OF INTERNAL MEDICINE

The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age-Period-Cohort Model

(2015) R. E. Gangnon et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

(2015) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial

(2015) Sue M Moss et al.   LANCET ONCOLOGY

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

(2015) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography

(2014) Natasha K. Stout et al.   JNCI-Journal of the National Cancer Institute

Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality

(2014) Diego Munoz et al.   JNCI-Journal of the National Cancer Institute

Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years

(2013) Nicolien T. van Ravesteyn   ANNALS OF INTERNAL MEDICINE

Which strategies reduce breast cancer mortality most?

(2013) Jeanne Mandelblatt et al.   CANCER

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Model Transparency and Validation

(2012) David M. Eddy et al.   MEDICAL DECISION MAKING

Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals

(2011) N T van Ravesteyn et al.   BRITISH JOURNAL OF CANCER

Race-Specific Impact of Natural History, Mammography Screening, and Adjuvant Treatment on Breast Cancer Mortality Rates in the United States

(2011) N. T. van Ravesteyn et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials

(2011) Wenjin Yin et al.   PLoS One

Digital mammography screening: Weighing reduced mortality against increased overdiagnosis

(2011) Rianne de Gelder et al.   PREVENTIVE MEDICINE